Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0

Alice P. Chen, Ann Setser, Milan J. Anadkat, Jonathan Cotliar, Elise A. Olsen, Benjamin C. Garden, Mario E. Lacouture

Research output: Contribution to journalReview articlepeer-review

216 Scopus citations

Abstract

Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.

Original languageEnglish
Pages (from-to)1025-1039
Number of pages15
JournalJournal of the American Academy of Dermatology
Volume67
Issue number5
DOIs
StatePublished - 2012

Keywords

  • Adverse events
  • Cancer treatment
  • Common terminology criteria for adverse events
  • Drug reactions
  • Grading system
  • Side effects

Fingerprint

Dive into the research topics of 'Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0'. Together they form a unique fingerprint.

Cite this